Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 604
Selected: 0
NCT IDTitle
NCT00496340Phase II Trial of Pentostatin and Targeted Busulfan
NCT01852591Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
NCT00215982Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
NCT00153933Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
NCT00006376R115777 in Treating Patients With Advanced Bladder Cancer
NCT05115474Study of Screening Brain MRIs in Stage IV Breast Cancer
NCT05681780Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
NCT06121180Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
NCT05070403Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
NCT01680965Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
NCT01681875Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT06109467Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
NCT04252612Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
NCT00006033Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
NCT03923270Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
NCT06047977Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors
NCT04798339Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
NCT01133275Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
NCT04585269Bright IDEAS - Young Adults Problem-Solving Skills Training
NCT05341882Adaptation of Mindfulness Training to Treat Moral Injury in Veterans
NCT01367990Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
NCT01450046Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects
NCT05677360HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)
NCT03575325Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT04760873Cryotherapy for GAVE
NCT05080946Using Aspirin to Improve Immunological Features of Ovarian Tumors
NCT00444015Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)
NCT00596011Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
NCT07249775A First-in-Human Study of FID-022 in Solid Tumor Patients
NCT01713400Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
NCT04879940Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
NCT03018223Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
NCT01630161Smoking Relapse-Prevention Intervention for Cancer Patients
NCT02634645TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
NCT03451383Older Breast Cancer Patients: Risk for Cognitive Decline
NCT06430346Exercise Prehabilitation for Locoregional Esophageal Cancer
NCT02901548Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
NCT06844097Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals
NCT00786760Natural History of HPV Infection in Men: The HIM Study
NCT04191187Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT05316116Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
NCT02402764Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC)
NCT02202499Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
NCT06144619Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT02945800Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
NCT01423006Pilot Study on Focal Prostate Radio-Frequency Ablation
NCT05233228Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
NCT02139358Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
NCT01400958Nuvigil or Placebo in Newly Diagnosed Malignant Glioma